Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Air Products Q2 Profit Down - Quick Facts

Air Products & Chemicals Inc. (APD: Quote) reported that its second-quarter net income attributable to the company decreased to $296.0 million or $1.38 per share, from $304.3 million or $1.39 per share in the same quarter last year.

The company reported net income of $281 million and earnings per share of $1.31 on a non-GAAP, continuing operations basis, for its fiscal second quarter ended March 31, 2012. Analysts polled by Thomson Reuters expected the company to report earnings of $1.33 per share for the quarter. Analysts' estimates typically exclude special items.

Sales for the quarter declined to $2.34 billion from $2.40 billion in the prior year quarter. Eleven analysts had consensus revenue estimate of $2.43 billion for the quarter.

Air Products expects third quarter adjusted earnings from continuing operations to be between $1.40 and $1.45 per share. Analysts expect the company to report earnings of $1.51 per share for the third-quarter.

For fiscal 2012, the company now expects GAAP earnings per share to be in the range of $5.26 to $5.39, and adjusted earnings from continuing operations of $5.47 to $5.60 per share. Analysts expect the company to report earnings of $5.75 per share for fiscal 2012.

While announcing the first-quarter results, the company expected earnings to be in the range of $5.90 to $6.30 per share.

Register
To receive FREE breaking news email alerts for Air Products And Chemicals Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Here is a list of interesting stocks to watch on December 19. The good news is you can skip this step. There is a next move that can make your life a lot easier. Our research team has already done the groundwork for you. All these stocks listed below and many more have been researched already, and... Shares of OvaScience Inc. (OVAS) have had a strong run in 2014, rising over 370 percent year-to-date. And that's indeed a very impressive return delivered by the fertility treatment company, which suffered a setback last year when it had to suspend a U.S. trial of its flagship fertility treatment due to regulatory concerns raised by the FDA. Nike Inc., the world's largest athletic shoes and apparel maker, said Thursday after the markets closed that its second quarter profit rose 23% from last year, helped by higher revenue and improved gross margin. The company's quarterly earnings per share also came in above analysts' expectations as did its quarterly revenue.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.